National Cancer Institute | GovernmentCIO Media & Research

National Cancer Institute

NCI is researching the role of telehealth in cancer care and developing best practices for continued integration.
The SBIR center takes a comprehensive approach to fostering underrepresented small businesses.
The Office of Cancer Survivorship takes a comprehensive look at cancer survivor care.
Public health researchers are developing methods for better detecting and predicting dangerous forms of cancer.
NCI is pushing the "bench to bedside" paradigm to bring medical advances into the clinic.
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
A recent NCI study explores new immunotherapy treatment for metastatic breast cancer.
Stay tuned for our monthly Cancer HealthCast miniseries to follow the future of cancer research and innovation.
At the end of April, Principal Deputy Director Dr. Douglas Lowy will serve as acting director.
The legislation set the foundation for the future of the war against cancer.
NCI’s SEER and CIS programs encourage ongoing engagement to further data sharing goals.
How NCI-designated cancer centers are supporting the national fight against cancer.
Data, communications tech, next-gen DNA sequencing and more have helped accelerate NCI's mission over the past 50 years.
In this episode of our National Cancer Act 50th anniversary miniseries, we dive into how NCI is fighting pediatric cancers.
In this latest episode of the National Cancer Act miniseries, we discuss progress in cancer prevention research and practice.
Making the fight against cancer more equitable requires diversifying cancer research, clinical trials and treatments.
Clinical trials, innovation in research and technology have improved cancer treatment and diagnostics in public health.
We delve into the history of cancer in America and talk to NCI Director Dr. Ned Sharpless on NCI's work the past 50 years.
HealthCast dives into the history and progress of legislation that kicked off decades of cancer care research and innovation.
Support for cancer research could see boosts in the new presidential administration.